STVN (Stevanato Group SpA) Accounts Payable: $295 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STVN Stevanato Group SpA STVN
86 GF Score
Price $20.32
GF Value $26.04
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Stevanato Group SpA Accounts Payable?

Stevanato Group SpA STVN -0.93% 86 Accounts Payable is $295 Mil as of Jun. 2026. GuruFocus rates STVN with a GF Score™ of 86/100 and a GF Value™ of $26.04 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Stevanato Group SpA's Accounts Payable for the quarter that ended in Jun. 2026 was $295 Mil.

Stevanato Group SpA's quarterly Accounts Payable declined from Dec. 2025 ($308 Mil) to Mar. 2026 ($294 Mil) but then increased from Mar. 2026 ($294 Mil) to Jun. 2026 ($295 Mil).

Stevanato Group SpA's annual Accounts Payable declined from Dec. 2023 ($303 Mil) to Dec. 2024 ($242 Mil) but then increased from Dec. 2024 ($242 Mil) to Dec. 2025 ($308 Mil).

Stevanato Group SpA Accounts Payable Related Terms

Stevanato Group SpA Accounts Payable Historical Data

* Premium members only.

The historical data trend for Stevanato Group SpA's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stevanato Group SpA Accounts Payable Chart

Stevanato Group SpA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 186.20 253.37 302.96 241.91 308.32

Stevanato Group SpA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 258.30 246.95 308.32 294.10 294.85
STVN
86GF Score
Stevanato Group SpA STVN
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stevanato Group SpA Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $295 Mil mean?
Stevanato Group SpA (STVN) has a Accounts Payable of $295 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Stevanato Group SpA and its competitors.
Is Stevanato Group SpA's Accounts Payable too high?
Stevanato Group SpA's current Accounts Payable is $295 Mil. Overall, Stevanato Group SpA has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Accounts Payable compare to MMED and TFX?
Stevanato Group SpA's Accounts Payable of $295 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Stevanato Group SpA and its competitors. Stevanato Group SpA's current Accounts Payable is $295 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (STVN) is currently considered Modestly Undervalued. The stock's GF Value™ is $26.04, compared to a current price of $20.32 — trading 22% below its estimated fair value. The current Accounts Payable is $295 Mil. Stevanato Group SpA's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Stevanato Group SpA (STVN), the current Accounts Payable is $295 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stevanato Group SpA (STVN) Overvalued in 2026?

Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued. The current stock price of $20.32 is trading 22% below its estimated GF Value™ of $26.04. GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.

Key valuation signals for STVN:

  • Accounts Payable: $295 Mil
  • GF Value™: $26.04 vs. price of $20.32 (22% below fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the STVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stevanato Group SpA Business Description

Other Exchanges 87N:Germany
Address Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
86GF Score

Get the complete analysis for STVN

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.32
Price
$26.04
GF Value